Alias

[(1R) -3-methyl-1-[[((2S) -1-oxo-3-phenyl-2-[(pyrazinyl) amino] propyl] amino] butyl] -boronic acid; Patzomi

Catalog Number

AP0100

CAS #

179324-69-7

Molecular Formula

C₁₉H₂₅BN₄O₄

Molecular Weight

384.24

Structural Formula

Product Introduction

CAS 179324-69-7

US-DMF No. 22884

 Bortezomib, the English name is Bortezomib, and the American Chemical Abstracts Registration Number is cas179324-69-7.

Bortezomib (cas 179324-69-7) is a reversible inhibitor of 26S proteasome chymotrypsin-like activity in mammalian cells. In vitro tests have proven that bortezomib is cytotoxic to many types of cancer cells. Preclinical tumor model in vivo tests have demonstrated that bortezomib can delay tumor growth, including multiple myeloma. This product is used for the treatment of patients with multiple myeloma, and its effectiveness is based on its effectiveness.